Search

everythinglearnresearchcommunity

for

Search:↓

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Skin symptoms can indicate endocrine disorders and have various treatments.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain drugs that block specific enzymes can help treat prostate diseases.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Raising awareness about PCOS can improve women's quality of life.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.